首页> 外文期刊>Therapeutic advances in cardiovascular disease. >Therapeutic procedures for coronary vasospasm-induced polymorphic ventricular tachycardia
【24h】

Therapeutic procedures for coronary vasospasm-induced polymorphic ventricular tachycardia

机译:冠状动脉痉挛诱发的多形性室性心动过速的治疗程序

获取原文
           

摘要

Coronary vasospasm is an unusual cause of angina and myocardial ischemia, with the potential to provoke acute myocardial infarction, malignant cardiac arrhythmias, and sudden cardiac death. The diagnosis is largely clinical and requires a high index of suspicion. Provocation studies are rarely performed due to the risks of the procedure and the relatively low incidence of disease. A subset of patients does not respond to conventional medical therapy and a paucity of evidence exists to guide therapy. While generally believed a multifocal phenomenon, there have been reports of successful treatment of focal, refractory vasospasm with coronary stent implantation. Furthermore, consideration of an implantable cardioverter defibrillator is warranted when vasospasm is complicated by lethal ventricular arrhythmias.
机译:冠状血管痉挛是心绞痛和心肌缺血的不常见原因,可能引起急性心肌梗塞,恶性心律不齐和心脏猝死。诊断主要是临床,需要高度怀疑。由于手术的风险和相对较低的疾病发生率,很少进行激发研究。一部分患者对常规药物治疗无反应,并且缺乏指导治疗的证据。尽管通常认为这是一种多灶性现象,但已有报道称通过冠状动脉支架植入术可以成功治疗局灶性难治性血管痉挛。此外,当血管痉挛并发致命性室性心律不齐时,应考虑使用植入式心脏复律除颤器。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号